Market revenue in 2023 | USD 498.4 million |
Market revenue in 2030 | USD 1,261.7 million |
Growth rate | 14.2% (CAGR from 2023 to 2030) |
Largest segment | Adult stem cells |
Fastest growing segment | Induced Pluripotent Stem Cells |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.47% in 2023. Horizon Databook has segmented the UK stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
The UK stem cell bank was established in 2003 for providing stem cells for research and clinical applications. Research pertaining to SCs and human embryos is controlled by the Human Fertilization and Embryology Authority (HFEA).
Under the guidelines provided by the organization, the UK has advanced in stem cell research and innovated technology platforms for clinical and health applications. iHuman is one such platform that provides the development of SCs for human health safety evaluation and application in regenerative medication.
The presence of organizations such as UK Stem Cell Bank (UKSCB), the Steering Committee for the Use of Stem Cell Lines, the Stem Cell Oversight Committee (SCOC), and the Human Fertilization and Embryology Authority (HFEA) in the UK that provides guidelines and funding for stem cell research is expected to continue contributing to the market growth in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the UK stem cells market , including forecasts for subscribers. This country databook contains high-level insights into UK stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account